TTP Plc (TTP), a leading independent technology and product development company, and Camena Bioscience, a developer of pioneering technology that profiles small molecules, such as metabolites, nutrients or medicines in liquid samples, announced today that they are collaborating to develop an instrument to monitor the health of cell cultures. The new instrument will be used in biologic medicine manufacturing, and will be developed by TTP as part of a new project led by Camena Bioscience and co-funded by Innovate UK, the UK’s innovation agency, with GSK plc and The Centre for Process Innovation as further project partners.
TTP will integrate Camena Bioscience’s proprietary small-molecule detection technology into a new instrument that will allow researchers to monitor metabolite levels in cell cultures more easily. The resulting better understanding of the condition of the cell culture, which is crucial for consistent synthesis of high-quality biologic products, promises to substant...
Cambridge, UK, 09 May 2018
Cambridge Healthtech Institute's Sixth International Molecular Diagnostics Europe event will return to Lisbon on 22-24 May 2018. This meeting provides a nexus for diagnostic developers in academia and industry as well as end-users in the pharmaceutical and healthcare sector to gain a comprehensive picture of molecular diagnostics in prenatal, oncology, infectious disease, point-of-care, and liquid biopsy.
Come and join our talk at the Point-of-Care Diagnostics Track on Thursday 24 May:
Time: 12:35 - 12:50
Title: A Robot in a Coffee Pod - An Overview of TTP's 'Puck', a Point-of-Care Diagnostics Platform
Speaker: Piers Harding, C.Eng FIMechE, Mechanical Engineer/Consultant, TTP plc
The past 5 years has seen a wave of new PoC diagnostic platforms entering the market, with intense competition to establish a leading position. Clearly, only a few of the contenders will be successful. At TTP, Europe’s leading independent technology development company, our engineers and mo...
22 - 24 May 2018, Lisbon, Portugal
TTP Group are sponsoring two events at the Pint of Science Festival, taking place on 14-16 May 2018. Join the research community at your local pub to hear about the latest research within Cambridge.
Antibiotic resistance is rising to dangerously high levels all over the world, and resistance mechanisms are threatening our ability to treat even common infectious diseases. While calls for new therapies are issued frequently, development of new successful drugs is becoming rare. This event explores new strategies towards successfully using antibiotics to treat infections, starting from understanding the mechanisms bacteria use to evade antibiotics, genomic approaches to improving antibiotic efficiency and other approaches researchers take to discover new ways of treating bacterial infections...
Speakers include: Pietro Mastroeni (Reader in Infection and Immunity), Julian Parkhill (Head of Infect...
14 - 16 May, Cambridge
ISCT is the premier cell therapy translation society focused on pre-clinical, clinical and translational aspects of developing cell therapy products. As such, ISCT helps academics, governmnt and biotech/ pharma sectors transform research into practice and product. The ISCT Annual Meeting will serve as the prime opportunity for networking with experts within the global cell therapy arena.
TTP Consultant, Dr Samson Rogers, will be presenting a poster on Cellular Highways at ISCT 2018, Poster Session 1 on Thursday 3 May, 18:00 - 19:30.
2 - 5 May, Palais des Congrès de Montréal
Melbourn Science Park
SG8 6EE UK
Tel: +44 1763 262626
Fax: +44 1763 261582
Registered number: 3304950
Registered office: as shown above
Country of registration: England & Wales
VAT number: 636 9859 76
The Technology Partnership plc is a TTP Group plc company.
© 2018 The Technology Partnership. All rights reserved.